VOLUME 14, ISSUE 6 / MARCH 2022
Regulatory
FEBRUARY 2022
China’s NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
- Yunfeng Lv
, - Yu Gao,
- Jingyun He,
- Chao Xu,
- Rongzhi Liu,
- Shengwei Zheng,
- Li Fang,
- Congyin Han &
- Ran Li
- Pages:317–324
- Published Online:21 February 2022
Research Article
MARCH 2022
Evaluation of the analytical performance of anti-SARS-CoV-2 antibody test kits distributed or developed in Japan
- Hiroko Shibata,
- Kazuko Nishimura,
- Takuya Maeda,
- Masamitsu Honma,
- Yukihiro Goda,
- Akiko Ishii-Watabe &
- Yoshiro Saito
- Pages:325–340
- Published Online:2 March 2022
Research Article
MARCH 2022
Systematic optimization of targeted and multiplexed MS-based screening workflows for protein biomarkers
- Neelam Khanal,
- Zhuo Chen,
- Yun W Alelyunas,
- Matthew E Szapacs,
- Mark D Wrona &
- Timothy W Sikorski
- Pages:341–356
- Published Online:8 March 2022
Research Article
MARCH 2022
Sensitive LC-MS/MS quantification of unconjugated maytansinoid DM4 and its metabolite S-methyl-DM4 in human plasma
- Yunlin Fu ,
- Shashank Gorityala,
- Wenkui Li ,
- David Humphries,
- Aaron Ledvina,
- Stephanie Cape &
- Franck Picard
- Pages:357–368
- Published Online:2 March 2022
Research Article
MARCH 2022
Development, validation and application of a liquid chromatography–tandem mass spectrometry method for the activity and inhibition of DPP-4
- Kees J Bronsema,
- Wietske Lambert,
- Stephane Charmont,
- Ramachandra Sangana,
- Radboud van Trigt &
- Marie-Anne Valentin
- Pages:369–378
- Published Online:7 March 2022